About the Company
BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BDSI News
Life sci consulting firm Santander launches with offer of commercial strategy guidance
There’s a new life-sciences-focused consulting firm in town. | There’s a new life-sciences-focused consulting firm in town.
What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now?
Below, we take a look at BioDelivery Sciences International (BDSI), which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score ...
BDSI Secures $7 Million Financing Commitment For Development of BEMA(TM) Fentanyl; Funding Targeted for Phase III Trials of Canc
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) (NASDAQ:BDSIW) announced today that it has entered into a clinical development and license agreement with Clinical Development Capital ...
BDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq Independence
BioDelivery Sciences International, Inc. (NASDAQ: BDSI, BDSIW) announced today that, effective September 15, 2005, Donald Ferguson and Alan Pearce have resigned from the company's board of directors.
BioDelivery Sciences Int’l (BDSI) Stock Dips in After-Hours Trading on Q4 Miss
BioDelivery Sciences Int’l (BDSI) is falling in after-hours trading on Thursday after the company posted its 2015 fourth quarter results after today’s closing bell. BioDelivery Sciences Int ...
BioDelivery Sciences International, Inc. (BDSI)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions.
Intellectual Property
In the interview below, he discusses changes to […] A drug delivery technology patent awarded to BioDelivery Sciences International (NASDAQ:BDSI) has triggered a $15 million milestone payment ...
Political Science & International Affairs
Are you curious about the inner workings of government or working with the public? The Department of Political Science & International Affairs (PSIA) currently offers six undergraduate degrees and two ...
Short Seller Behind Globe Life’s Plunge Has Winning Record
The record drop in Globe Life Inc. this week extended a streak of wins for the short-selling group that released a report ...
Political Science & International Affairs
Are you curious about the inner workings of government or working with the public? The Department of Political Science & International Affairs (PSIA) currently offers six undergraduate degrees and two ...
Loading the latest forecasts...